Citations (82)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
A. Taylor Kelley, Michael A. Incze, Jacob D. Baylis, Spencer G. Calder, Saul J. Weiner, Susan L. Zickmund, Audrey L. Jones, Megan E. Vanneman, Molly B. Conroy, Adam J. Gordon & John F.P. Bridges. (2022) Patient-centered quality measurement for opioid use disorder: Development of a taxonomy to address gaps in research and practice. Substance Abuse 43:1, pages 1286-1299.
Read now
Read now
Corey J. Hayes, Michael A. Cucciare, Bradley C. Martin, Teresa J. Hudson, Keith Bush, Weihsuan Lo-Ciganic, Hong Yu, Elizabeth Charron & Adam J. Gordon. (2022) Using data science to improve outcomes for persons with opioid use disorder. Substance Abuse 43:1, pages 956-963.
Read now
Read now
Rachel K. Landis, Jonathan S. Levin, Brendan Saloner, Adam J. Gordon, Andrew W. Dick, Tisamarie B. Sherry, Douglas L. Leslie, Mark Sorbero & Bradley D. Stein. (2022) Sociodemographic differences in quality of treatment to Medicaid enrollees receiving buprenorphine. Substance Abuse 43:1, pages 1057-1071.
Read now
Read now
Emmeline N. Taylor, Christine Timko, Ingrid A. Binswanger, Alex H. S. Harris, Matthew Stimmel, David Smelson & Andrea K. Finlay. (2022) A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration. Substance Abuse 43:1, pages 556-563.
Read now
Read now
Nicole Brunet, David T. Moore, Dora Lendvai Wischik, Kristin M. Mattocks & Marc I. Rosen. (2022) Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine. Substance Abuse 43:1, pages 39-46.
Read now
Read now
Natasha D. Perez-Rivera & Grace Chang. (2022) E-consultation for medications to treat opioid use disorders: a pilot study. Journal of Addictive Diseases 40:3, pages 428-431.
Read now
Read now
MacKenzie R. Peltier, Mehmet Sofuoglu, Ismene L. Petrakis, Elina Stefanovics & Robert A. Rosenheck. (2021) Sex Differences in Opioid Use Disorder Prevalence and Multimorbidity Nationally in the Veterans Health Administration. Journal of Dual Diagnosis 17:2, pages 124-134.
Read now
Read now
Brendan Saloner, Barbara Andraka Christou, Adam J. Gordon & Bradley D. Stein. (2021) It will end in tiers: A strategy to include “dabblers” in the buprenorphine workforce after the X-waiver. Substance Abuse 42:2, pages 153-157.
Read now
Read now
Aditya Narayan & Rajesh Balkrishnan. (2021) A health crisis within a health crisis: Opioid access in the COVID-19 pandemic. Substance Abuse 42:2, pages 148-152.
Read now
Read now
Gerald Cochran, Julie Bruneau, Nicholas Cox & Adam J. Gordon. (2020) Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic. Substance Abuse 41:3, pages 269-274.
Read now
Read now
Adam J. Gordon, Karen Drexler, Eric J. Hawkins, Jennifer Burden, Nodira K. Codell, Amy Mhatre-Owens, Matthew T. Dungan & Hildi Hagedorn. (2020) Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities. Substance Abuse 41:3, pages 275-282.
Read now
Read now
Ajay Manhapra, Elina Stefanovics & Robert Rosenheck. (2020) Initiating opioid agonist treatment for opioid use disorder nationally in the Veterans Health Administration: Who gets what?. Substance Abuse 41:1, pages 110-120.
Read now
Read now
Joseph W. Frank, Sarah E. Wakeman & Adam J. Gordon. (2018) No end to the crisis without an end to the waiver. Substance Abuse 39:3, pages 263-265.
Read now
Read now
Helen Valenstein-Mah, Hildi Hagedorn, Chad L. Kay, Melissa L. Christopher & Adam J. Gordon. (2018) Underutilization of the current clinical capacity to provide buprenorphine treatment for opioid use disorders within the Veterans Health Administration. Substance Abuse 39:3, pages 286-288.
Read now
Read now
Adam J. Gordon$suffix/text()$suffix/text() & Elizabeth M. Oliva$suffix/text()$suffix/text(). (2018) Applying and advancing best practices in opioid use disorder and addiction treatment: Introduction to the special issue on implementation science and quality improvement scholarship. Substance Abuse 39:2, pages 125-128.
Read now
Read now
Articles from other publishers (67)
Meagan M. Carr, Noah R. Wolkowicz, Shayna Cave, Steve Martino, Robin Masheb & Amanda M. Midboe. (2023) Weight change in a national cohort of U.S. Military Veterans engaged in medication treatment for opioid use disorder. Journal of Psychiatric Research 168, pages 204-212.
Crossref
Crossref
Madeline C. Frost, Carol A. Malte, Eric J. Hawkins, Joseph E. Glass, Kevin A. Hallgren & Emily C. Williams. (2023) Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders. Journal of Substance Use and Addiction Treatment 155, pages 209175.
Crossref
Crossref
Vilija R. Joyce, Elizabeth M. Oliva, Carla C. Garcia, Jodie Trafton, Steven M. Asch, Todd H. Wagner, Keith Humphreys, Douglas K. Owens & Mark Bounthavong. (2023) Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder. Addiction 118:11, pages 2203-2214.
Crossref
Crossref
Carla C. Garcia, Mark Bounthavong, Adam J. Gordon, Allison M. Gustavson, Marie E. Kenny, Wendy Miller, Aryan Esmaeili, Princess E. Ackland, Barbara A. Clothier, Ann Bangerter, Siamak Noorbaloochi, Alex H. S. Harris & Hildi J. Hagedorn. (2023) Costs of implementing a multi-site facilitation intervention to increase access to medication treatment for opioid use disorder. Implementation Science Communications 4:1.
Crossref
Crossref
Katherine J. Hoggatt, Neetu Chawla, Donna L. Washington & Elizabeth M. Yano. (2023) Trends in substance use disorder diagnoses among Veterans, 2009–2019. The American Journal on Addictions 32:4, pages 393-401.
Crossref
Crossref
Adam J. Gordon, Andrew J. Saxon, Stefan Kertesz, Jessica J. Wyse, Ajay Manhapra, Lewei A. Lin, Wei Chen, Jared Hansen, Derek Pinnell, Tina Huynh, Jacob D. Baylis, Francesca E. Cunningham, Udi E. Ghitza, Gavin Bart, Hong Yu & Brian C. Sauer. (2023) Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration. Drug and Alcohol Dependence 248, pages 109902.
Crossref
Crossref
A. Taylor Kelley, Jordynn Wilcox, Jacob D. Baylis, Norah L. Crossnohere, John Magel, Audrey L. Jones, Adam J. Gordon & John F. P. Bridges. (2022) Increasing Access to Buprenorphine for Opioid Use Disorder in Primary Care: an Assessment of Provider Incentives. Journal of General Internal Medicine 38:9, pages 2147-2155.
Crossref
Crossref
Jessica J. Wyse, Sarah Shull, Stephan Lindner, Benjamin J. Morasco, Adam J. Gordon, Kathleen F. Carlson, P. Todd Korthuis, Sarah S. Ono, Joseph G. Liberto & Travis I. Lovejoy. (2023) Access to Medications for Opioid Use Disorder in Rural Versus Urban Veterans Health Administration Facilities. Journal of General Internal Medicine 38:8, pages 1871-1876.
Crossref
Crossref
Madeline C. Frost, Elena M. Soyer, Carol E. Achtmeyer, Eric J. Hawkins, Joseph E. Glass, Kevin A. Hallgren & Emily C. Williams. (2023) Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings. Addiction Science & Clinical Practice 18:1.
Crossref
Crossref
Samantha G. Auty, Kyle D. Barr, Austin B. Frakt, Melissa M. Garrido & Kiersten L. Strombotne. (2023) Effect of a Veterans Health Administration mandate to case review patients with opioid prescriptions on mortality among patients with opioid use disorder: a secondary analysis of the STORM randomized control trial. Addiction 118:5, pages 870-879.
Crossref
Crossref
Madeline C. Frost, Eric J. Hawkins, Joseph E. Glass, Kevin A. Hallgren & Emily C. Williams. (2023) Associations Between Distinct Co-occurring Substance Use Disorders and Receipt of Medications for Opioid Use Disorder in the Veterans Health Administration. Journal of Addiction Medicine 17:3, pages 278-285.
Crossref
Crossref
Princess E. Ackland, Marie E. Kenny, Barbara A. Clothier, Hope A. Salameh, Natassia Boening, Adam J. Gordon, Siamak Noorbaloochi, Allison M. Gustavson, Wendy Miller & Hildi J. Hagedorn. (2023) What Contributes to Sustainability? Examining Access to Medications for Opioid Use Disorder in Low-Adopting VHA Facilities. Journal of General Internal Medicine.
Crossref
Crossref
Allison M. Gustavson, Hildi J. Hagedorn, Leah E. Jesser, Marie E. Kenny, Barbara A. Clothier, Mark Bounthavong, Princess E. Ackland, Adam J. Gordon & Alex H. S. Harris. (2022) Healthcare quality measures in implementation research: advantages, risks and lessons learned. Health Research Policy and Systems 20:1.
Crossref
Crossref
Jessica J. Wyse, Katherine Mackey, Travis I. Lovejoy, Devan Kansagara, Anais Tuepker, Adam J. Gordon, P. Todd Korthuis, Anders Herreid-O’Neill, Beth Williams & Benjamin J. Morasco. (2022) Expanding access to medications for opioid use disorder through locally-initiated implementation. Addiction Science & Clinical Practice 17:1.
Crossref
Crossref
Ismene Petrakis, Sandra A. Springer, Cynthia Davis, Elizabeth Ralevski, Lucy Gu, Robert Lew, John Hermos, Melynn Nuite, Adam J. Gordon, Thomas R. Kosten, Edward V. Nunes, Robert Rosenheck, Andrew J. Saxon, Robert Swift, Alexa Goldberg, Robert Ringer & Ryan Ferguson. (2022) Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans. Addiction Science & Clinical Practice 17:1.
Crossref
Crossref
Hildi J. Hagedorn, Allison M. Gustavson, Princess E. Ackland, Ann Bangerter, Mark Bounthavong, Barbara Clothier, Alex H. S. Harris, Marie E. Kenny, Siamak Noorbaloochi, Hope A. Salameh & Adam J. Gordon. (2022) Advancing Pharmacological Treatments for Opioid Use Disorder (ADaPT-OUD): an Implementation Trial in Eight Veterans Health Administration Facilities. Journal of General Internal Medicine 37:14, pages 3594-3602.
Crossref
Crossref
Joseph G Pickard, Carissa van den Berk-Clark & Monica M Matthieu. (2022) Association of Medication-Assisted Treatment and Age With Treatment Completion Among Veterans Seeking Non-VA Treatment for Opioid use Disorder at Non-Veterans Health Administration Facilities. Military Medicine 187:11-12, pages 1432-1440.
Crossref
Crossref
Madeline C. Frost, Lan Zhang, H. Myra Kim & Lewei (Allison) Lin. (2022) Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic. JAMA Network Open 5:10, pages e2236298.
Crossref
Crossref
Lewei (Allison) LinLan ZhangHyungjin Myra KimMadeline C. Frost. (2022) Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder. American Journal of Psychiatry 179:10, pages 740-747.
Crossref
Crossref
William Mullen, Michaela Hedberg, Brian Gadbois & Christian Heidbreder. (2022) The introduction of a novel formulation of buprenorphine into organized health systems. Drug and Alcohol Dependence Reports 4, pages 100090.
Crossref
Crossref
Jessica J. Wyse, Anders Herreid-O’Neill, Jacob Dougherty, Sarah Shull, Katherine Mackey, Kelsey C. Priest, Honora Englander, Jessica Thoma & Travis I. Lovejoy. (2021) Perioperative Management of Buprenorphine/Naloxone in a Large, National Health Care System: a Retrospective Cohort Study. Journal of General Internal Medicine 37:12, pages 2998-3004.
Crossref
Crossref
Kristin M. Mattocks, David T. Moore, Dora Lendvai Wischik, Christina M. Lazar & Marc I. Rosen. (2022) Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic. Journal of Substance Abuse Treatment 139, pages 108777.
Crossref
Crossref
Kerry L. Beckman, Emily C. Williams, Paul Hebert, Eric J. Hawkins, Alyson J. Littman & Keren Lehavot. (2022) The impact of military sexual trauma and gender on receipt of evidence-based medication treatment among veterans with opioid use disorder. Journal of Substance Abuse Treatment 139, pages 108775.
Crossref
Crossref
Madeline C. Frost, Julie E. Richards, John R. Blosnich, Eric J. Hawkins, Judith I. Tsui, E. Jennifer Edelman & Emily C. Williams. (2022) Association between clinically recognized suicidality and subsequent initiation or continuation of medications for opioid use disorder. Drug and Alcohol Dependence 237, pages 109521.
Crossref
Crossref
J. Priyanka Vakkalanka, Brian C. Lund, Marcia M. Ward, Stephan Arndt, R. William Field, Mary Charlton & Ryan M. Carnahan. (2021) Telehealth Utilization Is Associated with Lower Risk of Discontinuation of Buprenorphine: a Retrospective Cohort Study of US Veterans. Journal of General Internal Medicine 37:7, pages 1610-1618.
Crossref
Crossref
Ashley O. Radmall, Spencer Calder, Nodira Codell, Alan Taylor Kelley, Eric Hawkins, Audrey L. Jones, Hildi J. Hagedorn, Mary Anne Reynolds & Adam J. Gordon. (2022) Roles and Perceptions of Nurses During Implementation of a Medication Treatment for Opioid Use Disorder National Initiative. Journal of Addictions Nursing 33:2, pages 70-79.
Crossref
Crossref
Adam J. Gordon, Marie Kenny, Matthew Dungan, Allison M. Gustavson, A. Taylor Kelley, Audrey L. Jones, Eric Hawkins, Joseph W. Frank, Anissa Danner, Joseph Liberto & Hildi Hagedorn. (2022) Are x‐waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x‐waiver trainings. The American Journal on Addictions 31:2, pages 152-158.
Crossref
Crossref
Kerry L. Beckman, Emily C. Williams, Paul L. Hebert, Madeline C. Frost, Anna D. Rubinsky, Eric J. Hawkins, Alyson J. Littman & Keren Lehavot. (2022) Associations Among Military Sexual Trauma, Opioid Use Disorder, and Gender. American Journal of Preventive Medicine 62:3, pages 377-386.
Crossref
Crossref
Jessica J. Wyse, Kathleen A. McGinnis, E. Jennifer Edelman, Adam J. Gordon, Ajay Manhapra, David A. Fiellin, Brent A. Moore, P. Todd Korthuis, Amy J. Kennedy, Benjamin J. Oldfield, Julie R. Gaither, Kirsha S. Gordon, Melissa Skanderson, Declan T. Barry, Kendall Bryant, Stephen Crystal, Amy C. Justice & Kevin L. Kraemer. (2021) Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIV. AIDS and Behavior 26:3, pages 975-985.
Crossref
Crossref
Lewei A. Lin, John C. Fortney, Amy S.B. Bohnert, Lara N. Coughlin, Lan Zhang & John D. Piette. (2022) Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder. Journal of Substance Abuse Treatment 133, pages 108492.
Crossref
Crossref
Amy J. Kennedy, Kathleen A. McGinnis, Jessica S. Merlin, E. Jennifer Edelman, Adam J. Gordon, P. Todd Korthuis, Melissa Skanderson, Emily C. Williams, Jessica Wyse, Benjamin Oldfield, Kendall Bryant, Amy Justice, David A. Fiellin & Kevin L. Kraemer. (2022) Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV. Journal of Substance Abuse Treatment 132, pages 108509.
Crossref
Crossref
Lewei A. Lin, Erin E. Bonar, Lan Zhang, Rachel Girard & Lara N. Coughlin. (2022) Alcohol-involved overdose deaths in US veterans. Drug and Alcohol Dependence 230, pages 109196.
Crossref
Crossref
Allison M. Gustavson, Jennifer P. Wisdom, Marie E. Kenny, Hope A. Salameh, Princess E. Ackland, Barbara Clothier, Siamak Noorbaloochi, Adam J. Gordon & Hildi J. Hagedorn. (2021) Early impacts of a multi-faceted implementation strategy to increase use of medication treatments for opioid use disorder in the Veterans Health Administration. Implementation Science Communications 2:1.
Crossref
Crossref
Allison M. Gustavson, Marie E. Kenny, Jennifer P. Wisdom, Hope A. Salameh, Princess E. Ackland, Adam J. Gordon & Hildi J. Hagedorn. (2021) Fluctuations in barriers to medication treatment for opioid use disorder prescribing over the course of a one-year external facilitation intervention. Addiction Science & Clinical Practice 16:1.
Crossref
Crossref
Jack H. Ching, Douglas K. Owens, Jodie A. Trafton, Jeremy D. Goldhaber‐Fiebert & Joshua A. Salomon. (2021) Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration. Addiction 116:12, pages 3494-3503.
Crossref
Crossref
Eric J. Hawkins, Carol A. Malte, Adam J. Gordon, Emily C. Williams, Hildi J. Hagedorn, Karen Drexler, Brittany E. Blanchard, Jennifer L. Burden, Jennifer Knoeppel, Anissa N. Danner, Aline Lott, Joseph G. Liberto & Andrew J. Saxon. (2021) Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System. JAMA Network Open 4:12, pages e2137238.
Crossref
Crossref
Matthew R. Filteau, Brandn Green & Kristal Jones. (2021) Barriers to Community Treatment for Opioid Use Disorders among Rural Veterans. Journal of Veterans Studies 7:3, pages 83.
Crossref
Crossref
Jessica J. Wyse, Benjamin J. Morasco, Jacob Dougherty, Beau Edwards, Devan Kansagara, Adam J. Gordon, P. Todd Korthuis, Anaïs Tuepker, Stephan Lindner, Katherine Mackey, Beth Williams, Anders Herreid-O’Neill, Robin Paynter & Travis I. Lovejoy. (2021) Adjunct interventions to standard medical management of buprenorphine in outpatient settings: A systematic review of the evidence. Drug and Alcohol Dependence 228, pages 108923.
Crossref
Crossref
Douglas S. Krakower, Gary M. Naja-Riese, Zoe R. Edelstein, Anisha D. Gandhi, Amanda Wahnich & Michael A. Fischer. (2021) Academic Detailing to Increase Prescribing of HIV Pre-exposure Prophylaxis. American Journal of Preventive Medicine 61:5, pages S87-S97.
Crossref
Crossref
Erica Morse, Ingrid A. Binswanger, Emmeline Taylor, Caroline Gray, Matthew Stimmel, Christine Timko, Alex H.S. Harris, David Smelson & Andrea K. Finlay. (2021) Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study. Journal of Substance Abuse Treatment 129, pages 108353.
Crossref
Crossref
Madeline C. Frost, John R. Blosnich, Keren Lehavot, Jessica A. Chen, Anna D. Rubinsky, Joseph E. Glass & Emily C. Williams. (2021) Disparities in Documented Drug Use Disorders Between Transgender and Cisgender U.S. Veterans Health Administration Patients. Journal of Addiction Medicine 15:4, pages 334-340.
Crossref
Crossref
Hongjiao Wu, Ashutosh Dhar Dwivedi & Gautam Srivastava. (2021) Security and Privacy of Patient Information in Medical Systems Based on Blockchain Technology. ACM Transactions on Multimedia Computing, Communications, and Applications 17:2s, pages 1-17.
Crossref
Crossref
Benjamin A. Howell, Erica A. Abel, Dongchan Park, Sara N. Edmond, Leah J. Leisch & William C. Becker. (2020) Validity of Incident Opioid Use Disorder (OUD) Diagnoses in Administrative Data: a Chart Verification Study. Journal of General Internal Medicine 36:5, pages 1264-1270.
Crossref
Crossref
Pooja Lagisetty, Claire Garpestad, Angela Larkin, Colin Macleod, Derek Antoku, Stephanie Slat, Jennifer Thomas, Victoria Powell, Amy S.B. Bohnert & Lewei A. Lin. (2021) Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse. Drug and Alcohol Dependence 221, pages 108583.
Crossref
Crossref
Judith I. Tsui, Mary A. Akosile, Gwen T. Lapham, Denise M. Boudreau, Eric A. Johnson, Jennifer F. Bobb, Ingrid A. Binswanger, Bobbi Jo H. Yarborough, Joseph E. Glass, Rebecca C. Rossom, Mark T. Murphy, Chinazo O. Cunningham, Julia H. Arnsten, Manu Thakral, Andrew J. Saxon, Joseph O. Merrill, Jeffrey H. Samet, Gavin B. Bart, Cynthia I. Campbell, Amy M. Loree, Angela Silva, Angela L. Stotts, Brian Ahmedani, Jordan M Braciszewski, Rulin C. Hechter, Thomas F. Northrup, Viviana E. Horigian & Katharine A. Bradley. (2021) Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV. Journal of General Internal Medicine 36:4, pages 930-937.
Crossref
Crossref
Andrea K. Finlay, Alex H. S. Harris, Christine Timko, Mengfei Yu, David Smelson, Matthew Stimmel & Ingrid A. Binswanger. (2021) Disparities in Access to Medications for Opioid Use Disorder in the Veterans Health Administration. Journal of Addiction Medicine 15:2, pages 143-149.
Crossref
Crossref
Lewei A. Lin, Amy S. B. Bohnert, Frederic C. Blow, Adam J. Gordon, Rosalinda V. Ignacio, H. Myra Kim & Mark A. Ilgen. (2020) Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration. Addiction 116:1, pages 96-104.
Crossref
Crossref
Kelsey C. Priest, Dennis McCarty & Travis I. Lovejoy. (2020) Expanding Access to Medications for Opioid Use Disorder: Program and Policy Approaches from Outside the Veterans Health Administration. Journal of General Internal Medicine 35:S3, pages 886-890.
Crossref
Crossref
William C. Becker, Erin E. Krebs, Sara N. Edmond, Lewei A. Lin, Mark D. Sullivan, Roger D. Weiss & Adam J. Gordon. (2020) A Research Agenda for Advancing Strategies to Improve Opioid Safety: Findings from a VHA State of the Art Conference. Journal of General Internal Medicine 35:S3, pages 978-982.
Crossref
Crossref
Christine Timko & Katherine Hoggatt. (2020)
Commentary on Gibson
et al
. (2020): Medications for opioid use disorder– access, retention, and safety
. Addiction 115:11, pages 2077-2078.
Crossref
Crossref
Carlos Blanco, Mir M. Ali, Aaron Beswick, Karen Drexler, Cheri Hoffman, Christopher M. Jones, Tisha R. A. Wiley & Allan Coukell. (2020) The American Opioid Epidemic in Special Populations: Five Examples. NAM Perspectives.
Crossref
Crossref
Jennifer Jones, Matthew Tierney, Gabrielle Jacobs, Shao-Yun Chien & Sandra Mallisham. (2020) Empowering Psychiatric Mental Health Nurse Practitioners to Expand Treatment Opportunities for Veterans With Opioid Use Disorder. Journal of Addictions Nursing 31:4, pages 261-268.
Crossref
Crossref
Scott E. Hadland, Victoria A. Jent, Rachel H. Alinsky, Brandon D.L. Marshall, Pia M. Mauro & Magdalena Cerdá. (2020) Opioid Use Disorder Treatment Facilities With Programs for Special Populations. American Journal of Preventive Medicine 59:3, pages e125-e133.
Crossref
Crossref
Kelsey C. Priest, Travis I. Lovejoy, Honora Englander, Sarah Shull & Dennis McCarty. (2020) Opioid Agonist Therapy During Hospitalization Within the Veterans Health Administration: a Pragmatic Retrospective Cohort Analysis. Journal of General Internal Medicine 35:8, pages 2365-2374.
Crossref
Crossref
Audrey L. Jones, Stefan G. Kertesz, Leslie R.M. Hausmann, Maria K. Mor, Ying Suo, Warren B.P. Pettey, James H. SchaeferJrJr, Adi V. Gundlapalli & Adam J. Gordon. (2020) Primary care experiences of veterans with opioid use disorder in the Veterans Health Administration. Journal of Substance Abuse Treatment 113, pages 107996.
Crossref
Crossref
Hefei WenBenjamin G. DrussBrendan Saloner. (2020) Self-Help Groups And Medication Use In Opioid Addiction Treatment: A National Analysis. Health Affairs 39:5, pages 740-746.
Crossref
Crossref
Utibe R. Essien, Florentina E. Sileanu, Xinhua Zhao, Jane M. Liebschutz, Carolyn T. Thorpe, Chester B. Good, Maria K. Mor, Thomas R. Radomski, Leslie R. M. Hausmann, Michael J. Fine & Walid F. Gellad. (2020) Racial/Ethnic Differences in the Medical Treatment of Opioid Use Disorders Within the VA Healthcare System Following Non-Fatal Opioid Overdose. Journal of General Internal Medicine 35:5, pages 1537-1544.
Crossref
Crossref
Andrew S. Huhn, J. Gregory Hobelmann, Justin C. Strickland, George A. Oyler, Cecilia L. Bergeria, Annie Umbricht & Kelly E. Dunn. (2020) Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States. JAMA Network Open 3:2, pages e1920843.
Crossref
Crossref
Amanda J. Abraham, Christina M. Andrews, Samantha J. Harris & Peter D. Friedmann. (2020) Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA. Neurotherapeutics 17:1, pages 55-69.
Crossref
Crossref
Kevin L. Kraemer, Kathleen A. McGinnis, David A. Fiellin, Melissa Skanderson, Adam J. Gordon, Jonathan Robbins, Susan Zickmund, Kendall Bryant & P. Todd Korthuis. (2019) Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans. Journal of Substance Abuse Treatment 103, pages 23-32.
Crossref
Crossref
Lewei (Allison) Lin, Talya Peltzman, John F. McCarthy, Elizabeth M. Oliva, Jodie A. Trafton & Amy S.B. Bohnert. (2019) Changing Trends in Opioid Overdose Deaths and Prescription Opioid Receipt Among Veterans. American Journal of Preventive Medicine 57:1, pages 106-110.
Crossref
Crossref
Jessica J. Wyse, Jonathan L. Robbins, Kathleen A. McGinnis, E. Jennifer Edelman, Adam J. Gordon, Ajay Manhapra, David A. Fiellin, Brent A. Moore, P. Todd Korthuis, Julie R. Gaither, Kirsha Gordon, Melissa Skanderson, Declan T. Barry, Stephen Crystal, Amy Justice & Kevin L. Kraemer. (2019) Predictors of timely opioid agonist treatment initiation among veterans with and without HIV. Drug and Alcohol Dependence 198, pages 70-75.
Crossref
Crossref
Sarah Meshberg-Cohen, Anne C. Black, Jason C. DeViva, Ismene L. Petrakis & Marc I. Rosen. (2019) Trauma treatment for veterans in buprenorphine maintenance treatment for opioid use disorder. Addictive Behaviors 89, pages 29-34.
Crossref
Crossref
Ramin MojtabaiChristine MauroMelanie M. WallColleen L. BarryMark Olfson. (2019) Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities. Health Affairs 38:1, pages 14-23.
Crossref
Crossref
Hildi Hagedorn, Marie Kenny, Adam J. Gordon, Princess E. Ackland, Siamak Noorbaloochi, Wei Yu & Alex H. S. Harris. (2018) Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities. Addiction Science & Clinical Practice 13:1.
Crossref
Crossref
Stacey C. Conroy & James M. Bjork. (2018) Death Ambivalence and Treatment Seeking: Suicidality in Opiate Addiction. Current Treatment Options in Psychiatry 5:3, pages 291-300.
Crossref
Crossref
Claudio Deiana, Ludovica Giua & Roberto Nisticò. (2019) The Economics Behind the Epidemic: Afghan Opium Price and Prescription Opioids in the US. SSRN Electronic Journal.
Crossref
Crossref